Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy

Por Alhamlan, Fatimah S, Al-Ahdal, Mohammed N, Khalaf, Nisreen Z, Abdo, Ayman A, Sanai, Faisal, Al-Ashgar, Hamad I, Al-Qahtani, Ahmed A
Publicado em 2014

Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

Por Alhamlan, Fatimah S, Al-Ahdal, Mohammed N, Khalaf, Nisreen Z, Abdo, Ayman A, Sanai, Faisal M, Al-Ashgar, Hamad I, ElHefnawi, Mahmoud, Zaid, Amina, Al-Qahtani, Ahmed A
Publicado em 2014

Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia

Por Al-Anazi, Mashael R, Matou-Nasri, Sabine, Abdo, Ayman A, Sanai, Faisal M, Khan, Mohammed Q, Albenmousa, Ali, Al-Ashgar, Hamad I, Khalaf, Nisreen Z, Al-Ahdal, Mohammed N, Al-Qahtani, Ahmed A
Publicado no BMC Infect Dis (2014)

Association between HLA Variations and Chronic Hepatitis B Virus Infection in Saudi Arabian Patients

Por Al-Qahtani, Ahmed A., Al-Anazi, Mashael R., Abdo, Ayman A., Sanai, Faisal M., Al-Hamoudi, Waleed, Alswat, Khalid A., Al-Ashgar, Hamad I., Khalaf, Nisreen Z., Eldali, Abdelmoneim M., Viswan, Nisha A., Al-Ahdal, Mohammed N.
Publicado em 2014